Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease.
Wang Z, Tian L, Jiang Y, Ning L, Zhu X, Chen X, Xuan B, Zhou Y, Ding J, Ma Y, Zhao Y, Huang X, Hu M, Fang JY, Shen N, Cao Z, Chen H, Wang X, Hong J.
Cell Metab. 2025 May 6;37(5):1089-1102.e7. doi: 10.1016/j.cmet.2025.01.007. Epub 2025 Feb 19.
Enterococci enhance Clostridioides difficile pathogenesis.
Smith AB, Jenior ML, Keenan O, Hart JL, Specker J, Abbas A, Rangel PC, Di C, Green J, Bustin KA, Gaddy JA, Nicholson MR, Laut C, Kelly BJ, Matthews ML, Evans DR, Van Tyne D, Furth EE, Papin JA, Bushman FD, Erlichman J, Baldassano RN, Silverman MA, Dunny GM, Prentice BM, Skaar EP, Zackular JP.
Nature. 2022 Nov;611(7937):780-786. doi: 10.1038/s41586-022-05438-x. Epub 2022 Nov 16.
Reprogramming neuroblastoma by diet-enhanced polyamine depletion.
Cherkaoui S, Turn CS, Yuan Y, Lu W, Yang L, McBride MJ, Eigenmann C, Allen GE, Panasenko OO, Zhang L, Vu A, Liu K, Li Y, Gandhi OH, Surrey LF, Kienast SD, Leidel SA, Wierer M, White E, Rabinowitz JD, Hogarty MD, Morscher RJ.
Nature. 2025 Oct;646(8085):707-715. doi: 10.1038/s41586-025-09564-0. Epub 2025 Sep 24.
Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota.
Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M, Nagatake T, Konishi K, Ohno H, Tanisawa K, Mohsen A, Chen YA, Kawashima H, Natsume-Kitatani Y, Oka Y, Shimizu H, Furuta M, Tojima Y, Sawane K, Saika A, Kondo S, Yonejima Y, Takeyama H, Matsutani A, Mizuguchi K, Miyachi M, Kunisawa J.
Nat Commun. 2022 Aug 18;13(1):4477. doi: 10.1038/s41467-022-32015-7.
LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages.
Wei Z, Oh J, Flavell RA, Crawford JM.
Nature. 2022 Sep;609(7926):348-353. doi: 10.1038/s41586-022-05111-3. Epub 2022 Aug 17.
The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Martinelli D, Diodato D, Ponzi E, Monné M, Boenzi S, Bertini E, Fiermonte G, Dionisi-Vici C.
Orphanet J Rare Dis. 2015 Mar 11;10:29. doi: 10.1186/s13023-015-0242-9.
FMO2 Promotes Angiogenesis via Regulation of N-Acetylornithine.
Wang J, Xu Y, Wu X, Li M, Xiao C, Fu Z, Chen Y, Li Q, Ruan Y, Zhao J, Zhong Z, Chen J, Zhu W, Nan J, Ni C, Hu X.
Adv Sci (Weinh). 2025 Dec;12(48):e06618. doi: 10.1002/advs.202506618. Epub 2025 Oct 6.
Ornithine phenylacetate revisited.
Jover-Cobos M, Noiret L, Sharifi Y, Jalan R.
Metab Brain Dis. 2013 Jun;28(2):327-31. doi: 10.1007/s11011-013-9391-5. Epub 2013 Mar 2.
Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.
Coutelier M, Goizet C, Durr A, Habarou F, Morais S, Dionne-Laporte A, Tao F, Konop J, Stoll M, Charles P, Jacoupy M, Matusiak R, Alonso I, Tallaksen C, Mairey M, Kennerson M, Gaussen M, Schule R, Janin M, Morice-Picard F, Durand CM, Depienne C, Calvas P, Coutinho P, Saudubray JM, Rouleau G, Brice A, Nicholson G, Darios F, Loureiro JL, Zuchner S, Ottolenghi C, Mochel F, Stevanin G.
Brain. 2015 Aug;138(Pt 8):2191-205. doi: 10.1093/brain/awv143. Epub 2015 May 29.
Oxidative ornithine metabolism supports non-inflammatory C. difficile colonization.
Pruss KM, Enam F, Battaglioli E, DeFeo M, Diaz OR, Higginbottom SK, Fischer CR, Hryckowian AJ, Van Treuren W, Dodd D, Kashyap P, Sonnenburg JL.
Nat Metab. 2022 Jan;4(1):19-28. doi: 10.1038/s42255-021-00506-4. Epub 2022 Jan 6.
